(Abst.) Fatal COVID-19 in an MS patient on natalizumab... on: August 29, 2020, 03:19:57 pm #1 From PubMed (August 29, 2020)--"Fatal COVID-19 in an MS patient on natalizumab: A case report": Fatal COVID-19 in an MS patient on natalizumab: A case report - PubMed We report a fatal case of COVID-19 in a 51-year-old African American woman with multiple sclerosis on natalizumab. She had multiple risk factors for severe COVID-19 disease including race, obesity,... PubMed · pubmed.ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
